2024, Vol 14, No. 6

Editor-in-Chief

Prof. Khosro Adibkia

Original Research

1. Synthesis of New Functionalized Citric Acid-based Dendrimers as Nanocarrier Agents for Drug Delivery

Hassan Namazi*, Sanaz Motamedi, Mina Namvari

Bioimpacts. 2011;1(1): 63-69. doi: 10.5681/bi.2011.009

PMCID: PMC3648942 PMID: 23678409 Scopus ID: 84876698090

Article

PDF

XML

Cited By:

Original Research

2. Drug nanocarrier agents based on starch-g-amino acids

Hassan Namazi*, Elnaz Abdollahzadeh

Bioimpacts. 2018;8(2): 99-106. doi: 10.15171/bi.2018.12

PMCID: PMC6026521 PMID: 29977831 Scopus ID: 85048075763

Article

PDF

Full Text

XML

Cited By:

Original Research

3. Carboxymethylcellulose/MOF-5/Graphene oxide bio-nanocomposite as antibacterial drug nanocarrier agent

Zahra Karimzadeh, Siamak Javanbakht, Hassan Namazi*

Bioimpacts. 2019;9(1): 5-13. doi: 10.15171/bi.2019.02

PMCID: PMC6378098 PMID: 30788255 Scopus ID: 85060437287

Article

PDF

Full Text

XML

Cited By:

105

Carboxymethylcellulose/MOF-5/Graphene oxide bio-nanocomposite was synthesized through a solvothermal technique, which it could encapsulate tetracycline. The drug release tests showed the stability of drug dosing in the gastrointestinal tract conditions. Antibacterial tests exhibited suitable activity to negatively charge E. coli bacteria.

Editorial

4. Recent advances in targeted therapy of colorectal cancer: impacts of monoclonal antibodies nanoconjugates

Mostafa Akbarzadeh Khiavi , Azam Safary , Mohammad Hossein Somi*

Bioimpacts. 2019;9(3): 123-127. doi: 10.15171/bi.2019.16

PMCID: PMC6726747 PMID: 31508327 Scopus ID: 85071152476

Article

PDF

Full Text

XML

Cited By:

Colorectal cancer (CRC) as a malignancy shows high mortality rate worldwide because of metastasis and drug resistance. Targeted multimodal nanosystems (NSs) can be developed and used against CRC with much better clinical outcomes.

Editorial

5. Targeted delivery of thrombolytic enzymes

Young M. Kwon*

BioImpacts. 2021;11(2): 85-86. doi: 10.34172/bi.2021.15

PMCID: PMC8022233 PMID: 33842278 Scopus ID: 85106598035

Article

PDF

Full Text

XML

Cited By:

Young M. Kwon received his Ph.D. from University of Utah (USA) and his postdoctoral training at University of Michigan (USA). He is currently an Associate Professor of Pharmaceutical Sciences at Nova Southeastern University College of Pharmacy (USA). Dr. Kwon’s research interests include targeted delivery and controlled release of biological molecules.

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons